Johnson & Johnson

Patient reported fairly large volume of hair starting to come out upon brushing starting 03/22/21. Hair loss still occurring as of 04/05/21. Patient has never had this problem in the past. No other med changes have taken place. This report matches a few others by word of mouth within our company.

RASH; ITCHY AREAS ON SHOULDER, EARS WAISTLINES, THIGHS AND ARMS; This spontaneous report received from a patient concerned a 90 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced itchy areas on shoulder, ears waistlines, thighs and arms. On 11-APR-2021, the subject experienced rash. Treatment medications (dates unspecified) included: calamine/camphor/diphenhydramine hydrochloride/glycerol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itchy areas on shoulder, ears waistlines, thighs and arms, and the outcome of rash was not reported. This report was non-serious.

Resident had Johnson Vaccine on 6/25 at approximately 11:30am, had no initial symptoms on the day of vaccination. On 6/26, resident was alert and verbal all day, VS 98.1-93-18-119/77-95% on R/A , respositioned frequently in bed, at 5pm CNA was doing care and alerted nurse of res c/o not feeling well " I feel like im going to die" fingertips purple unable to obtain 02sat, color pale temp 98.3, pulse 110, RR 22, BP 87/53 res stating " please rush me to the hospital" , HCP and MD contacted, transfer orders given, resident left facility via ambulance at 5:20pm. Per hospital on 6/27 at 7:00AM resident in the ICU at this time.

ALLERGIC REACTION WAS RASH IN BLOTCHES AND HIVES THAT MOVED ALL AROUND THE BODY, SEVERE ITCHING. DIZZINESS, WEAKNESS, TIREDNESS, HOT AND COLD FLASHES ALL CONTINUEING FOR NOW THE 6TH DAY FOLLOWING VACCINE.

Onset of shingles rash and pain on the chin and peri-articula area on the right side also red right eye

pt presented at store today with a bruise on her upper left calf. she did not remember hitting her leg. she noticed it after her janssen covid vaccine. I advised pt to seek medical attention due to the risk of low platelets/blood clots- under advisement of the EUA. Pt was going to get looked at Med Express.

BLACK AND BLUE MARK AT SITE OF INJECTION; SHE FELT PAIN DURING THE INJECTION OF THE VACCINE; This spontaneous report received from a patient concerned a 94 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included deaf. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination on left arm. The batch number was not reported and has been requested. No concomitant medications were reported. On 19-MAR-2021, the subject experienced black and blue mark at site of injection. On 19-MAR-2021, the subject experienced pain. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient had not recovered from black and blue mark at site of injection, and the outcome of pain was not reported. This report was non-serious.

INJECTION SITE HAS A MASS BRUISE COLOR BLACK AND BLUE WITH RED DOT IN THE MIDDLE; LT ARM IS HEAVY; NO ENERGY; WORN OUT; This spontaneous report received from a patient concerned a 94 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cancer, asthma, hypertension, arthritis, and carpal tunnel, and other pre-existing medical conditions included the patient had no known allergies and did not had any drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAY-2021, the subject experienced injection site has a mass bruise color black and blue with red dot in the middle. On 29-MAY-2021, the subject experienced lt arm is heavy. On 29-MAY-2021, the subject experienced no energy. On 29-MAY-2021, the subject experienced worn out. On 29-MAY-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tired, no energy, lt arm is heavy, and worn out, and the outcome of injection site has a mass bruise color black and blue with red dot in the middle was not reported. This report was non-serious.

SHE STARTED FEELING ILL THE NEXT DAY AND THEN 4 DAYS LATER SHE STARTED GETTING LARGE RED SPOTS WENT TO URGENT CARE AND THEY INFORMED US THAT SHE HAD SHINGLES...AND IT WAS CAUSED BY THE COVID SHOT.

SWELLING AT INJECTION SITE; REDNESS AT INJECTION SITE; SORENESS TO THE INJECTION SITE OF THE LEFT ARM; This spontaneous report received from a health care professional concerned a 99 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on 22-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-JUN-2021, the subject experienced soreness to the injection site of the left arm. On 02-JUL-2021, the subject experienced swelling at injection site. On 02-JUL-2021, the subject experienced redness at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered with sequelae from soreness to the injection site of the left arm on 22-JUN-2021, and had not recovered from swelling at injection site, and redness at injection site. This report was non-serious.